Literature DB >> 12407086

Autosomal-dominant hypoplastic form of amelogenesis imperfecta caused by an enamelin gene mutation at the exon-intron boundary.

M Kida1, T Ariga, T Shirakawa, H Oguchi, Y Sakiyama.   

Abstract

Amelogenesis imperfecta (AI) is currently classified into 14 distinct subtypes based on various phenotypic criteria; however, the gene responsible for each phenotype has not been defined. We performed molecular genetic studies on a Japanese family with a possible autosomal-dominant form of AI. Previous studies have mapped an autosomal-dominant human AI locus to chromosome 4q11-q21, where two candidate genes, ameloblastin and enamelin, are located. We studied AI patients in this family, focusing on these genes, and found a mutation in the enamelin gene. The mutation detected was a heterozygous, single-G deletion within a series of 7 G residues at the exon 9-intron 9 boundary of the enamelin gene. The mutation was detected only in AI patients in the family and was not detected in other unaffected family members or control individuals. The male proband and his brother showed hypoplastic enamel in both their deciduous and permanent teeth, and their father showed local hypoplastic defects in the enamel of his permanent teeth. The clinical phenotype of these patients is similar to that of the first report of AI caused by an enamelin gene mutation. Thus, heterogeneous mutations in the enamelin gene are responsible for an autosomal-dominant hypoplastic form of AI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407086     DOI: 10.1177/0810738

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  33 in total

1.  Amelogenesis imperfecta due to a mutation of the enamelin gene: clinical case with genotype-phenotype correlations.

Authors:  Rochelle G Lindemeyer; Carolyn W Gibson; Timothy J Wright
Journal:  Pediatr Dent       Date:  2010 Jan-Feb       Impact factor: 1.874

Review 2.  DENTAL ENAMEL FORMATION AND IMPLICATIONS FOR ORAL HEALTH AND DISEASE.

Authors:  Rodrigo S Lacruz; Stefan Habelitz; J Timothy Wright; Michael L Paine
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

3.  Altered enamelin phosphorylation site causes amelogenesis imperfecta.

Authors:  H-C Chan; L Mai; A Oikonomopoulou; H L Chan; A S Richardson; S-K Wang; J P Simmer; J C-C Hu
Journal:  J Dent Res       Date:  2010-05-03       Impact factor: 6.116

4.  ENAM mutations with incomplete penetrance.

Authors:  F Seymen; K-E Lee; M Koruyucu; K Gencay; M Bayram; E B Tuna; Z H Lee; J-W Kim
Journal:  J Dent Res       Date:  2014-08-20       Impact factor: 6.116

5.  Tooth enamel proteins enamelin and amelogenin cooperate to regulate the growth morphology of octacalcium phosphate crystals.

Authors:  Mayumi Iijima; Daming Fan; Keith M Bromley; Zhi Sun; Janet Moradian-Oldak
Journal:  Cryst Growth Des       Date:  2010-11       Impact factor: 4.076

6.  Target gene analyses of 39 amelogenesis imperfecta kindreds.

Authors:  Hui-Chen Chan; Ninna M R P Estrella; Rachel N Milkovich; Jung-Wook Kim; James P Simmer; Jan C-C Hu
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

Review 7.  The molecular etiologies and associated phenotypes of amelogenesis imperfecta.

Authors:  J Timothy Wright
Journal:  Am J Med Genet A       Date:  2006-12-01       Impact factor: 2.802

8.  MMP20 active-site mutation in hypomaturation amelogenesis imperfecta.

Authors:  D Ozdemir; P S Hart; O H Ryu; S J Choi; M Ozdemir-Karatas; E Firatli; N Piesco; T C Hart
Journal:  J Dent Res       Date:  2005-11       Impact factor: 6.116

9.  Hypoplastic AI with Highly Variable Expressivity Caused by ENAM Mutations.

Authors:  M Koruyucu; J Kang; Y J Kim; F Seymen; Y Kasimoglu; Z H Lee; T J Shin; H K Hyun; Y J Kim; S H Lee; J C C Hu; J P Simmer; J W Kim
Journal:  J Dent Res       Date:  2018-03-19       Impact factor: 6.116

10.  Exclusion of candidate genes in seven Turkish families with autosomal recessive amelogenesis imperfecta.

Authors:  Sema Becerik; Dilsah Cogulu; Gülnur Emingil; Ted Han; P Suzanne Hart; Thomas C Hart
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.